{"organizations": [], "uuid": "ad06c9fd9d32ae50206fed87d1bed2e3d19c2f73", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 1, "shares": 1, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-gsks-viiv-healthcare-says-filed-pa/brief-gsks-viiv-healthcare-says-filed-patent-infringement-litigation-against-gilead-sciences-idUSFWN1PY04Q", "country": "US", "domain_rank": 408, "title": "BRIEF-GSK's ViiV Healthcare Says Filed Patent Infringement Litigation Against Gilead Sciences", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-02-08T15:17:00.000+02:00", "replies_count": 0, "uuid": "ad06c9fd9d32ae50206fed87d1bed2e3d19c2f73"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-gsks-viiv-healthcare-says-filed-pa/brief-gsks-viiv-healthcare-says-filed-patent-infringement-litigation-against-gilead-sciences-idUSFWN1PY04Q", "ord_in_thread": 0, "title": "BRIEF-GSK's ViiV Healthcare Says Filed Patent Infringement Litigation Against Gilead Sciences", "locations": [], "entities": {"persons": [], "locations": [{"name": "canada", "sentiment": "none"}], "organizations": [{"name": "glaxosmithkline plc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "healthcare says filed patent infringement litigation against gilead sciences feb", "sentiment": "negative"}, {"name": "gilead sciences inc", "sentiment": "none"}, {"name": "plc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 8 (Reuters) - Glaxosmithkline Plc:\n* VIIV FILES PATENT INFRINGEMENT LITIGATION * GLAXOSMITHKLINE PLC - VIIV ‍ANNOUNCED IT FILED PATENT INFRINGEMENT LITIGATION AGAINST GILEAD SCIENCES INC. OVER BICTEGRAVIR IN UNITED STATES AND CANADA​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T15:17:00.000+02:00", "crawled": "2018-02-09T16:45:53.033+02:00", "highlightTitle": ""}